breast cancer: be more common in developed countries

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents breast
Weight: 0.78
, prostate cancer
Weight: 0.76
, heart disease
Weight: 0.75
, tumor
Weight: 0.72
, illness
Weight: 0.72
Siblings lung cancer
Weight: 0.80
, lymphoma
Weight: 0.60
, skin cancer
Weight: 0.40
, liver cancer
Weight: 0.39

Related properties

Property Similarity
be more common in developed countries 1.00
be more common in countries 0.95
be more common in western countries 0.91
is more common 0.87
be common in states 0.86
is common now 0.83
is most common 0.83
is common 0.83
be common in united states 0.81
be more common in females 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.46
Rule weight: 0.66
Evidence weight: 0.73
Similarity weight: 0.95
Evidence: 0.53
Plausible(heart disease, be more common in countries)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.46
Rule weight: 0.66
Evidence weight: 0.80
Similarity weight: 0.86
Evidence: 0.65
Plausible(heart disease, be common in states)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.40
Rule weight: 0.66
Evidence weight: 0.61
Similarity weight: 1.00
Evidence: 0.32
Plausible(heart disease, be more common in developed countries)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.37
Rule weight: 0.66
Evidence weight: 0.68
Similarity weight: 0.83
Evidence: 0.44
Plausible(prostate cancer, is common)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.35
Rule weight: 0.66
Evidence weight: 0.66
Similarity weight: 0.81
Evidence: 0.41
Plausible(heart disease, be common in united states)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.35
Rule weight: 0.66
Evidence weight: 0.63
Similarity weight: 0.83
Evidence: 0.36
Plausible(heart disease, is common)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
0.33
Rule weight: 0.66
Evidence weight: 0.61
Similarity weight: 0.83
Evidence: 0.32
Plausible(illness, is common)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)

Plausibility inheritance from parent to child

0.08
Rule weight: 0.09
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.32
¬ Plausible(heart disease, be more common in developed countries)
0.06
Rule weight: 0.09
Evidence weight: 0.73
Similarity weight: 0.95
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.53
¬ Plausible(heart disease, be more common in countries)
0.06
Rule weight: 0.09
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.32
¬ Plausible(illness, is common)
0.06
Rule weight: 0.09
Evidence weight: 0.82
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.36
¬ Plausible(heart disease, is common)
0.06
Rule weight: 0.09
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.41
¬ Plausible(heart disease, be common in united states)
0.06
Rule weight: 0.09
Evidence weight: 0.77
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.44
¬ Plausible(prostate cancer, is common)
0.05
Rule weight: 0.09
Evidence weight: 0.67
Similarity weight: 0.86
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.65
¬ Plausible(heart disease, be common in states)

Remarkability exclusitivity betweem a parent and a child

0.51
Rule weight: 0.58
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.23
¬ Remarkable(heart disease, be more common in developed countries)
0.41
Rule weight: 0.58
Evidence weight: 0.76
Similarity weight: 0.95
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.50
¬ Remarkable(heart disease, be more common in countries)
0.37
Rule weight: 0.58
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.44
¬ Remarkable(heart disease, be common in united states)
0.35
Rule weight: 0.58
Evidence weight: 0.70
Similarity weight: 0.86
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.62
¬ Remarkable(heart disease, be common in states)
0.27
Rule weight: 0.58
Evidence weight: 0.57
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.88
¬ Remarkable(illness, is common)
0.27
Rule weight: 0.58
Evidence weight: 0.56
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.90
¬ Remarkable(prostate cancer, is common)
0.26
Rule weight: 0.58
Evidence weight: 0.55
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.94
¬ Remarkable(heart disease, is common)

Remarkability exclusitivity between siblings

0.11
Rule weight: 0.13
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.40
¬ Remarkable(lymphoma, be more common in developed countries)
0.10
Rule weight: 0.13
Evidence weight: 0.76
Similarity weight: 0.95
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Remarkable(lymphoma, be more common in countries)
0.07
Rule weight: 0.13
Evidence weight: 0.61
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.81
¬ Remarkable(lung cancer, is most common)
0.07
Rule weight: 0.13
Evidence weight: 0.60
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.83
¬ Remarkable(skin cancer, is most common)
0.06
Rule weight: 0.13
Evidence weight: 0.56
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.90
¬ Remarkable(lung cancer, is common)
0.06
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.92
¬ Remarkable(skin cancer, is common)

Remarkability from parent implausibility

0.35
Rule weight: 0.42
Evidence weight: 0.88
Similarity weight: 0.95
Evidence: 0.53
Plausible(heart disease, be more common in countries)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.35
Rule weight: 0.42
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.32
Plausible(heart disease, be more common in developed countries)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.33
Rule weight: 0.42
Evidence weight: 0.91
Similarity weight: 0.86
Evidence: 0.65
Plausible(heart disease, be common in states)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.30
Rule weight: 0.42
Evidence weight: 0.86
Similarity weight: 0.83
Evidence: 0.44
Plausible(prostate cancer, is common)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.29
Rule weight: 0.42
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.36
Plausible(heart disease, is common)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.29
Rule weight: 0.42
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.41
Plausible(heart disease, be common in united states)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)
0.29
Rule weight: 0.42
Evidence weight: 0.83
Similarity weight: 0.83
Evidence: 0.32
Plausible(illness, is common)
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Plausible(breast cancer, be more common in developed countries)

Remarkability from sibling implausibility

0.49
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.92
Remarkable(skin cancer, is common)
Evidence: 0.44
¬ Plausible(skin cancer, is common)
0.49
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.90
Remarkable(lung cancer, is common)
Evidence: 0.46
¬ Plausible(lung cancer, is common)
0.47
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.83
Remarkable(skin cancer, is most common)
Evidence: 0.68
¬ Plausible(skin cancer, is most common)
0.47
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.81
Remarkable(lung cancer, is most common)
Evidence: 0.70
¬ Plausible(lung cancer, is most common)
0.46
Rule weight: 0.60
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.40
Remarkable(lymphoma, be more common in developed countries)
Evidence: 0.75
¬ Plausible(lymphoma, be more common in developed countries)
0.46
Rule weight: 0.60
Evidence weight: 0.80
Similarity weight: 0.95
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.49
Remarkable(lymphoma, be more common in countries)
Evidence: 0.78
¬ Plausible(lymphoma, be more common in countries)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.50
¬ Salient(breast cancer, be more common in developed countries)

Similarity expansion

0.68
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.08
¬ Typical(breast cancer, is common now)
0.68
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.10
¬ Typical(breast cancer, is common)
0.66
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.95
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.45
¬ Typical(breast cancer, be more common in countries)
0.63
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.87
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.36
¬ Typical(breast cancer, is more common)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.91
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.38
¬ Remarkable(breast cancer, be more common in western countries)
0.61
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.95
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.48
¬ Plausible(breast cancer, be more common in countries)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.30
¬ Plausible(breast cancer, is common now)
0.60
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.37
¬ Typical(breast cancer, is most common)
0.59
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.33
¬ Plausible(breast cancer, is common)
0.58
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.91
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.49
¬ Salient(breast cancer, be more common in western countries)
0.56
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.91
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.54
¬ Plausible(breast cancer, be more common in western countries)
0.56
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.87
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.48
¬ Plausible(breast cancer, is more common)
0.56
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.95
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.62
¬ Salient(breast cancer, be more common in countries)
0.55
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.91
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.69
¬ Typical(breast cancer, be more common in western countries)
0.54
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.86
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.63
¬ Typical(breast cancer, be common in states)
0.53
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.81
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.45
¬ Remarkable(breast cancer, be common in united states)
0.53
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.81
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.46
¬ Salient(breast cancer, be common in united states)
0.53
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.83
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.51
¬ Plausible(breast cancer, is most common)
0.52
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.81
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.48
¬ Plausible(breast cancer, be common in united states)
0.52
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.81
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.59
¬ Typical(breast cancer, be common in united states)
0.50
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.86
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.62
¬ Plausible(breast cancer, be common in states)
0.50
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.95
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.76
¬ Remarkable(breast cancer, be more common in countries)
0.50
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.83
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.60
¬ Salient(breast cancer, is common now)
0.49
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.83
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.61
¬ Salient(breast cancer, is common)
0.48
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.81
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.72
¬ Typical(breast cancer, be more common in females)
0.48
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.87
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.71
¬ Salient(breast cancer, is more common)
0.47
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.86
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.71
¬ Remarkable(breast cancer, be common in states)
0.47
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.81
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.63
¬ Remarkable(breast cancer, be more common in females)
0.46
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.86
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.74
¬ Salient(breast cancer, be common in states)
0.45
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.81
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.67
¬ Plausible(breast cancer, be more common in females)
0.44
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.83
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.75
¬ Salient(breast cancer, is most common)
0.43
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.81
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.76
¬ Salient(breast cancer, be more common in females)
0.40
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.87
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.88
¬ Remarkable(breast cancer, is more common)
0.38
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.83
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.90
¬ Remarkable(breast cancer, is most common)
0.36
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.83
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.95
¬ Remarkable(breast cancer, is common)
0.36
Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.83
Evidence: 0.48
Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.97
¬ Remarkable(breast cancer, is common now)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.50
Salient(breast cancer, be more common in developed countries)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)

Typical implies Plausible

0.34
Rule weight: 0.48
Evidence weight: 0.71
Similarity weight: 1.00
Evidence: 0.49
Plausible(breast cancer, be more common in developed countries)
Evidence: 0.58
¬ Typical(breast cancer, be more common in developed countries)

Typicality and Rermarkability incompatibility between a parent and a child

0.39
Rule weight: 0.51
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.15
¬ Typical(heart disease, is common)
0.39
Rule weight: 0.51
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.15
¬ Typical(illness, is common)
0.38
Rule weight: 0.51
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.54
¬ Typical(heart disease, be more common in developed countries)
0.37
Rule weight: 0.51
Evidence weight: 0.86
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.28
¬ Typical(prostate cancer, is common)
0.34
Rule weight: 0.51
Evidence weight: 0.70
Similarity weight: 0.95
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.62
¬ Typical(heart disease, be more common in countries)
0.31
Rule weight: 0.51
Evidence weight: 0.76
Similarity weight: 0.81
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.50
¬ Typical(heart disease, be common in united states)
0.29
Rule weight: 0.51
Evidence weight: 0.66
Similarity weight: 0.86
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.70
¬ Typical(heart disease, be common in states)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.26
¬ Typical(skin cancer, is common)
0.10
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.30
¬ Typical(lung cancer, is common)
0.08
Rule weight: 0.14
Evidence weight: 0.58
Similarity weight: 1.00
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.87
¬ Typical(lymphoma, be more common in developed countries)
0.08
Rule weight: 0.14
Evidence weight: 0.70
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.63
¬ Typical(skin cancer, is most common)
0.08
Rule weight: 0.14
Evidence weight: 0.69
Similarity weight: 0.83
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.64
¬ Typical(lung cancer, is most common)
0.08
Rule weight: 0.14
Evidence weight: 0.58
Similarity weight: 0.95
Evidence: 0.48
¬ Remarkable(breast cancer, be more common in developed countries)
Evidence: 0.86
¬ Typical(lymphoma, be more common in countries)

Typicality inheritance from parent to child

0.38
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.15
¬ Typical(heart disease, is common)
0.38
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.15
¬ Typical(illness, is common)
0.38
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.54
¬ Typical(heart disease, be more common in developed countries)
0.35
Rule weight: 0.48
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.28
¬ Typical(prostate cancer, is common)
0.34
Rule weight: 0.48
Evidence weight: 0.74
Similarity weight: 0.95
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.62
¬ Typical(heart disease, be more common in countries)
0.31
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 0.81
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.50
¬ Typical(heart disease, be common in united states)
0.30
Rule weight: 0.48
Evidence weight: 0.71
Similarity weight: 0.86
Evidence: 0.58
Typical(breast cancer, be more common in developed countries)
Evidence: 0.70
¬ Typical(heart disease, be common in states)